Dr. Andreas Schmidt

Co-Founder and Managing Director of Springboard Health Angels, serial biotech entrepreneur who has built deep-tech life science startups in Asia, Europe, and the US. Co-founded Proteona (single-cell multi-omics company) and led it as CEO until acquisition by Singleron Biotechnologies. Earlier co-founded AYOXXA Biosystems. PhD in Immunology from UC Berkeley and Unkiversity of Cologne. Formely headed Global Business Development at Singleron, applying single-cell technologies to precision medicine. Extensive experience in biotech startup finance and strategy.

Europe certainly has the ingredients: world-class science, exceptional talent, strong healthcare systems and a remarkable industrial base.
But great science alone does not create growth.

We need to turn more European innovation into globally competitive companies. That means entrepreneurial ambition, faster and more courageous capital, better conditions for scaling — and perhaps most importantly, the willingness to think bigger.